Developer docs
API playgroundTry for free, no card

Search company profiles

AlphaStem

Full company profile

uuid000ht7d

Namestring
AlphaStem
Legal namestring
Electromedical Products International, Inc.
Websiteurl
alpha-stim.com
Company typeenum
Private
Founded yearint
1981
Descriptiontext

Alpha-Stim, legally Electromedical Products International, Inc., is a privately held US medical device company founded in 1981 and headquartered in Mineral Wells, Texas. The company designs, manufactures, and markets FDA 510(k)-cleared Class II electrotherapy devices for the drug-free treatment of anxiety, insomnia, depression (approved outside the US), and acute, chronic, and post-traumatic pain. Its core technology rests on two proprietary modalities: Cranial Electrotherapy Stimulation (CES), delivered via earclip electrodes to modulate brain network activity, and Microcurrent Electrical Therapy (MET), delivered via handheld Smart Probes or self-adhesive AS-Trodes for localized pain relief. The flagship Alpha-Stim M device uniquely combines both CES and MET in a single handheld unit; the Alpha-Stim AID provides CES-only functionality. Both are protected by three granted US patents (8,612,008; 8,457,765; 8,463,406), and the company's clinical evidence dossier exceeds 100 studies covering 8,800+ participants accumulated over 40+ years.

The company sells hardware directly to consumers through alpha-stim.com at $882 for the AID and $1,363 for the M, plus a full accessories line (electrode pads, lead wires, conducting solution, carry cases) priced $10.50-$42 that generates recurring revenue. In the US, a prescription is required and can be obtained either through a healthcare provider or via the company's telehealth referral program at $99 per appointment (available in most states except Rhode Island and Vermont); internationally, devices are available over-the-counter. Alpha-Stim also operates the Provider Plus Program, which offers volume discounts and clinical education to healthcare practitioners and clinics, and publishes practitioner-targeted webinars covering integrative, telehealth, addiction, and psychiatry applications. Customer segments span individual consumers, US veterans and active military, first responders (police, fire, EMS), healthcare providers, professional sports organizations, and a long-tail of celebrity and influencer users — supported by a multi-channel marketing strategy spanning the company website, social media (Facebook, YouTube, LinkedIn, Instagram), testimonial content, and clinical research publications. The company has no disclosed external VC/PE backing and has remained bootstrapped through its 40+ year operating history.

Short descriptiontext

Alpha-Stim is a privately held US medical device company that manufactures FDA-cleared Class II electrotherapy devices (Alpha-Stim AID and Alpha-Stim M) using patented Cranial Electrotherapy Stimulation and Microcurrent Electrical Therapy to treat anxiety, insomnia, depression, and pain without drugs, selling directly to consumers, veterans, first responders, and healthcare providers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAtlanta, United States
HQ citystring
Atlanta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cranial electrotherapy stimulation, microcurrent electrical therapy, pain management devices, mental health treatment, FDA-cleared medical devices
Industry1 code
PRIMARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Neuromodulation Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

One-time hardware sales of Alpha-Stim AID ($882) and Alpha-Stim M ($1,363) devices. Includes 30-day money-back guarantee and 5-year limited warranty. Payment options include HSA/FSA funds, credit/debit cards, PayPal, and monthly payment plans.

alpha-stim.com
2Accessories and Consumables
TypeHardware Sales
Description

Recurring sales of replacement accessories including earclip electrodes, probe electrode pads, AS-Trode self-adhesive electrode pads, conducting solution refills, carry cases, and lead wires. Prices range from $10.50 to $42.00 per item.

alpha-stim.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details3 tiers
1Alpha-Stim AID device for anxiety, insomnia, and depression
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Alpha-Stim AID costs $882. Includes earclip electrodes for CES therapy, 30-day money-back guarantee, and 5-year limited warranty.

alpha-stim.com
2Alpha-Stim M device for pain, anxiety, insomnia, and depression
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Alpha-Stim M costs $1,363. Includes earclip electrodes for CES, Smart Probes and AS-Trodes for MET pain therapy, 30-day money-back guarantee, and 5-year limited warranty.

alpha-stim.com
3Accessories and replacement parts
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Accessories include: Carry cases ($20), Box of 256 felt earclip electrode pads ($21), Box of 100 probe electrode pads ($21), Earclip electrodes ($42), AS-Trode self-adhesive silver electrode pads ($25), Replacement lead wire ($10.50), Smart Probe ($15.75), Conducting solution refill ($15.75).

alpha-stim.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Alpha-Stim AID
Description

FDA-cleared cranial electrotherapy stimulation (CES) device for treating anxiety, insomnia, and depression.

alpha-stim.com
+1 more record
Core offering1 text field

Alpha-Stim manufactures and sells FDA-cleared handheld electrotherapy medical devices that deliver patented Cranial Electrotherapy Stimulation (CES) and Microcurrent Electrical Therapy (MET) to treat anxiety, insomnia, depression (outside the US), and acute, chronic, and post-traumatic pain. Its two flagship products, the Alpha-Stim AID (CES-only, $882) and Alpha-Stim M (CES + MET, $1,363), are sold direct-to-consumer via the alpha-stim.com website and dispensed through licensed healthcare providers and a telehealth prescription network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 61% average decrease in anxiety immediately after CES treatment; 94% after 5 weeks
+4 more records
Product overview1 text field

Alpha-Stim is a neuromodulation medical device company offering two primary FDA-cleared electrotherapy products: Alpha-Stim AID and Alpha-Stim M. Alpha-Stim AID is a cranial electrotherapy stimulation (CES) device for treating anxiety, insomnia, and depression, priced at $882. Alpha-Stim M combines CES and microcurrent electrical therapy (MET) to treat acute, chronic, and post-traumatic pain as well as anxiety, insomnia, and depression, priced at $1,363. Both devices use patented low-amplitude waveforms delivered via earclip electrodes. Alpha-Stim M additionally includes handheld Smart Probes and AS-Trode self-adhesive electrodes for targeted pain treatment. The product portfolio is supported by a comprehensive range of accessories including carry cases, electrode pads, conducting solution, and replacement parts. The company also provides telehealth consultation services and a mobile application for device control.

Product and service3 records
1Alpha-Stim AID
CategoryElectrotherapy medical device (CES)
Description

FDA-cleared Class II cranial electrotherapy stimulation (CES) device that uses earclip electrodes to deliver a patented low-amplitude waveform to the brain for sustainable, long-term relief from anxiety, insomnia, and depression. Intended for adult consumers with a prescription (US) or OTC purchase (international).

2Alpha-Stim M
CategoryElectrotherapy medical device (CES + MET)
Description

FDA-cleared Class II medical device combining cranial electrotherapy stimulation (CES) for anxiety, insomnia, and depression with microcurrent electrical therapy (MET) for acute, chronic, and post-traumatic pain. Includes earclip electrodes and handheld Smart Probes or self-adhesive AS-Trode electrodes for targeted pain treatment.

3Alpha-Stim Felt Earclip and Probe Electrode Pads, Lead Wires, AS-Trodes, Conducting Solution, and Carry Cases
CategoryDevice accessories and consumables
Description

Recurring-use consumables and accessories for Alpha-Stim AID and Alpha-Stim M devices, including boxes of 256 felt earclip electrode pads ($21), boxes of 100 probe electrode pads ($21), Alpha-Stim AID and M earclip electrodes ($42 each), AS-Trode self-adhesive silver electrode pads ($25), replacement lead wires for Alpha-Stim M ($10.50), Alpha-Stim M Smart Probes ($15.75), conducting solution refills ($15.75), and carry cases for both AID and M ($20 each).

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Cala Health develops FDA-cleared wearable electrical stimulation devices (Cala Trio for essential tremor) and is expanding into broader neurology indications — comparable as a transcutaneous neurostim company navigating FDA clearance and provider channels.

TypeBroad incumbent
Description

Soterix Medical develops clinical-grade transcranial direct current stimulation (tDCS) and other neurostimulation platforms used in research and clinical settings — comparable as a neuromodulation hardware company serving mental health and pain indications.

TypeBroad incumbent
Description

Inspire markets an FDA-approved implantable neurostimulation device for obstructive sleep apnea, demonstrating the broader neurostim category's commercial and regulatory economics relevant to Alpha-Stim's insomnia positioning.

TypeEmerging player
Description

Pulsetto is an emerging consumer vagus-nerve stimulation device focused on stress, anxiety, and sleep — overlapping with Alpha-Stim's mental wellness use cases through a lower-friction consumer OTC channel.

TypeBroad incumbent
Description

ElectroCore commercializes non-invasive vagus nerve stimulation (nVNS) devices (gammaCore) for migraine, cluster headache, and other neurological indications — comparable as a non-implantable, FDA-cleared neurostim business targeting chronic conditions.

TypeDirect peer
Description

Fisher Wallace makes FDA-cleared cranial electrotherapy stimulation (CES) devices for anxiety, insomnia, and depression — directly competing with Alpha-Stim AID on the same CES modality, indications, and direct-to-consumer channel.

7Apollo Neuroscience
TypeDirect peer
Description

Apollo produces a consumer wearable that delivers low-amplitude stimulation to modulate the nervous system for stress, sleep, and focus — overlapping with Alpha-Stim's mental wellness/stress indications via a consumer-DTC motion.

TypeBroad incumbent
Description

NeuroPace markets an FDA-approved responsive neurostimulation system (RNS) for refractory epilepsy — adjacent to Alpha-Stim as a commercial neuromodulation business operating in CNS indications under FDA regulation.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AlphaStem

Neuromodulation Medical Devicesalpha-stim.com

Alpha-Stim is a privately held US medical device company that manufactures FDA-cleared Class II electrotherapy devices (Alpha-Stim AID and Alpha-Stim M) using patented Cranial Electrotherapy Stimulation and Microcurrent Electrical Therapy to treat anxiety, insomnia, depression, and pain without drugs, selling directly to consumers, veterans, first responders, and healthcare providers.

What AlphaStem does

Alpha-Stim, legally Electromedical Products International, Inc., is a privately held US medical device company founded in 1981 and headquartered in Mineral Wells, Texas. The company designs, manufactures, and markets FDA 510(k)-cleared Class II electrotherapy devices for the drug-free treatment of anxiety, insomnia, depression (approved outside the US), and acute, chronic, and post-traumatic pain. Its core technology rests on two proprietary modalities: Cranial Electrotherapy Stimulation (CES), delivered via earclip electrodes to modulate brain network activity, and Microcurrent Electrical Therapy (MET), delivered via handheld Smart Probes or self-adhesive AS-Trodes for localized pain relief. The flagship Alpha-Stim M device uniquely combines both CES and MET in a single handheld unit; the Alpha-Stim AID provides CES-only functionality. Both are protected by three granted US patents (8,612,008; 8,457,765; 8,463,406), and the company's clinical evidence dossier exceeds 100 studies covering 8,800+ participants accumulated over 40+ years.

The company sells hardware directly to consumers through alpha-stim.com at $882 for the AID and $1,363 for the M, plus a full accessories line (electrode pads, lead wires, conducting solution, carry cases) priced $10.50-$42 that generates recurring revenue. In the US, a prescription is required and can be obtained either through a healthcare provider or via the company's telehealth referral program at $99 per appointment (available in most states except Rhode Island and Vermont); internationally, devices are available over-the-counter. Alpha-Stim also operates the Provider Plus Program, which offers volume discounts and clinical education to healthcare practitioners and clinics, and publishes practitioner-targeted webinars covering integrative, telehealth, addiction, and psychiatry applications. Customer segments span individual consumers, US veterans and active military, first responders (police, fire, EMS), healthcare providers, professional sports organizations, and a long-tail of celebrity and influencer users — supported by a multi-channel marketing strategy spanning the company website, social media (Facebook, YouTube, LinkedIn, Instagram), testimonial content, and clinical research publications. The company has no disclosed external VC/PE backing and has remained bootstrapped through its 40+ year operating history.

AlphaStem firmographics

Firmographics
Name
AlphaStem
Legal name
Electromedical Products International, Inc.
Website
https://alpha-stim.com
Company type
Private
Founded year
1981
Operating status
Operating
Headcount range
51–100 employees
Short description
Alpha-Stim is a privately held US medical device company that manufactures FDA-cleared Class II electrotherapy devices (Alpha-Stim AID and Alpha-Stim M) using patented Cranial Electrotherapy Stimulation and Microcurrent Electrical Therapy to treat anxiety, insomnia, depression, and pain without drugs, selling directly to consumers, veterans, first responders, and healthcare providers.
Ownership category
akta.pro rank

AlphaStem industry classification

Industry
Product category
Neuromodulation Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

  • Cranial electrotherapy stimulation
  • Microcurrent electrical therapy
  • Pain management devices
  • Mental health treatment
  • FDA-cleared medical devices

Where AlphaStem is headquartered

Location

Headquarters

HQ city
Atlanta
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AlphaStem business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device Sales: One-time hardware sales of Alpha-Stim AID ($882) and Alpha-Stim M ($1,363) devices. Includes 30-day money-back guarantee and 5-year limited warranty. Payment options include HSA/FSA funds, credit/debit cards, PayPal, and monthly payment plans.
  2. Accessories and Consumables: Recurring sales of replacement accessories including earclip electrodes, probe electrode pads, AS-Trode self-adhesive electrode pads, conducting solution refills, carry cases, and lead wires. Prices range from $10.50 to $42.00 per item.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goAlpha-Stim AID device for anxiety, insomnia, and depression
One time/ perpetual licensePay-as-you-goAlpha-Stim M device for pain, anxiety, insomnia, and depression
Unit PricingPay-as-you-goAccessories and replacement parts

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

AlphaStem product offering

Product offering

Core offering

Alpha-Stim manufactures and sells FDA-cleared handheld electrotherapy medical devices that deliver patented Cranial Electrotherapy Stimulation (CES) and Microcurrent Electrical Therapy (MET) to treat anxiety, insomnia, depression (outside the US), and acute, chronic, and post-traumatic pain. Its two flagship products, the Alpha-Stim AID (CES-only, $882) and Alpha-Stim M (CES + MET, $1,363), are sold direct-to-consumer via the alpha-stim.com website and dispensed through licensed healthcare providers and a telehealth prescription network.

Product overview

Alpha-Stim is a neuromodulation medical device company offering two primary FDA-cleared electrotherapy products: Alpha-Stim AID and Alpha-Stim M. Alpha-Stim AID is a cranial electrotherapy stimulation (CES) device for treating anxiety, insomnia, and depression, priced at $882. Alpha-Stim M combines CES and microcurrent electrical therapy (MET) to treat acute, chronic, and post-traumatic pain as well as anxiety, insomnia, and depression, priced at $1,363. Both devices use patented low-amplitude waveforms delivered via earclip electrodes. Alpha-Stim M additionally includes handheld Smart Probes and AS-Trode self-adhesive electrodes for targeted pain treatment. The product portfolio is supported by a comprehensive range of accessories including carry cases, electrode pads, conducting solution, and replacement parts. The company also provides telehealth consultation services and a mobile application for device control.

Differentiator

Problem solved

Functional benefit

Brands

  • Alpha-Stim AID: FDA-cleared cranial electrotherapy stimulation (CES) device for treating anxiety, insomnia, and depression.
  • Alpha-Stim M

Products and services

  • Alpha-Stim AID FDA-cleared Class II cranial electrotherapy stimulation (CES) device that uses earclip electrodes to deliver a patented low-amplitude waveform to the brain for sustainable, long-term relief from anxiety, insomnia, and depression. Intended for adult consumers with a prescription (US) or OTC purchase (international).
  • Alpha-Stim M FDA-cleared Class II medical device combining cranial electrotherapy stimulation (CES) for anxiety, insomnia, and depression with microcurrent electrical therapy (MET) for acute, chronic, and post-traumatic pain. Includes earclip electrodes and handheld Smart Probes or self-adhesive AS-Trode electrodes for targeted pain treatment.
  • Alpha-Stim Felt Earclip and Probe Electrode Pads, Lead Wires, AS-Trodes, Conducting Solution, and Carry Cases Recurring-use consumables and accessories for Alpha-Stim AID and Alpha-Stim M devices, including boxes of 256 felt earclip electrode pads ($21), boxes of 100 probe electrode pads ($21), Alpha-Stim AID and M earclip electrodes ($42 each), AS-Trode self-adhesive silver electrode pads ($25), replacement lead wires for Alpha-Stim M ($10.50), Alpha-Stim M Smart Probes ($15.75), conducting solution refills ($15.75), and carry cases for both AID and M ($20 each).

Quantifiable outcome

  • 61% average decrease in anxiety immediately after CES treatment; 94% after 5 weeks
  • +4 more outcomes

Companies that use AlphaStem

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

AlphaStem technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

AlphaStem partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

AlphaStem competitors and assessment

Company assessment

Broad incumbents

  • Cala Health: Cala Health develops FDA-cleared wearable electrical stimulation devices (Cala Trio for essential tremor) and is expanding into broader neurology indications — comparable as a transcutaneous neurostim company navigating FDA clearance and provider channels.
  • Soterix Medical: Soterix Medical develops clinical-grade transcranial direct current stimulation (tDCS) and other neurostimulation platforms used in research and clinical settings — comparable as a neuromodulation hardware company serving mental health and pain indications.
  • Inspire Medical Systems: Inspire markets an FDA-approved implantable neurostimulation device for obstructive sleep apnea, demonstrating the broader neurostim category's commercial and regulatory economics relevant to Alpha-Stim's insomnia positioning.
  • ElectroCore: ElectroCore commercializes non-invasive vagus nerve stimulation (nVNS) devices (gammaCore) for migraine, cluster headache, and other neurological indications — comparable as a non-implantable, FDA-cleared neurostim business targeting chronic conditions.
  • NeuroPace: NeuroPace markets an FDA-approved responsive neurostimulation system (RNS) for refractory epilepsy — adjacent to Alpha-Stim as a commercial neuromodulation business operating in CNS indications under FDA regulation.

Emerging players

  • Pulsetto: Pulsetto is an emerging consumer vagus-nerve stimulation device focused on stress, anxiety, and sleep — overlapping with Alpha-Stim's mental wellness use cases through a lower-friction consumer OTC channel.

Direct peers

  • Fisher Wallace Laboratories: Fisher Wallace makes FDA-cleared cranial electrotherapy stimulation (CES) devices for anxiety, insomnia, and depression — directly competing with Alpha-Stim AID on the same CES modality, indications, and direct-to-consumer channel.
  • Apollo Neuroscience: Apollo produces a consumer wearable that delivers low-amplitude stimulation to modulate the nervous system for stress, sleep, and focus — overlapping with Alpha-Stim's mental wellness/stress indications via a consumer-DTC motion.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

AlphaStem social profiles

Digital presence

AlphaStem compliance and trust

Trust signal

Compliance1 record

AlphaStem financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AlphaStem leadership team

Management profile

Number of profiles

Profiles2 records

AlphaStem funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AlphaStem M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AlphaStem

What does AlphaStem do?

Alpha-Stim manufactures and sells FDA-cleared handheld electrotherapy medical devices that deliver patented Cranial Electrotherapy Stimulation (CES) and Microcurrent Electrical Therapy (MET) to treat anxiety, insomnia, depression (outside the US), and acute, chronic, and post-traumatic pain. Its two flagship products, the Alpha-Stim AID (CES-only, $882) and Alpha-Stim M (CES + MET, $1,363), are sold direct-to-consumer via the alpha-stim.com website and dispensed through licensed healthcare providers and a telehealth prescription network.

Is AlphaStem a public or private company?

AlphaStem is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AlphaStem founded?

AlphaStem was founded in 1981. It employs 51 to 100 people.

Where is AlphaStem based?

AlphaStem is headquartered in Atlanta, United States, in the North America region.

How does AlphaStem make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are accessories and Consumables.

Who are AlphaStem's main competitors?

Broad incumbents on record are Cala Health, Soterix Medical, Inspire Medical Systems, ElectroCore and NeuroPace. Pulsetto is listed as an emerging player. Direct peers are Fisher Wallace Laboratories and Apollo Neuroscience.

Does AlphaStem have an API?

No public API is recorded for AlphaStem.

What industry is AlphaStem in?

AlphaStem's product category is Neuromodulation Medical Devices. Its primary akta.pro industry code is CRACAQAL, Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales